Latest Trials Latest NewsFAQ

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Modeling Stress-precipitated Smoking Behavior for Medication Development

Phase 2

Completed

Conditions: Smoking

Interventions: Drug: guanfacine
Drug: placebo

First Posted Date: 2008-10-16

Last Posted Date: 2022-08-03

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00773357

Locations: 🇺🇸
Yale Center for Clinical Investigation, Yale University, New Haven, Connecticut, United States

Detection of Ischemia in Asymptomatic Diabetics

Completed

Conditions: Type 2 Diabetes Mellitus

First Posted Date: 2008-10-09

Last Posted Date: 2008-10-09

Lead Sponsor: Yale University

Target Recruit Count: 1123

Registration Number: NCT00769275

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis

Phase 3

Terminated

Conditions: Pregnancy
Infertility

Interventions: Behavioral: Timed intercourse
Procedure: Microsurgical varicocelectomy
Procedure: Intrauterine insemination

First Posted Date: 2008-10-07

Last Posted Date: 2013-07-02

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT00767338

Locations: 🇺🇸
University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

and more 6 locations

Cortical GABA Concentrations in Insomnia

Completed

Conditions: Insomnia
Major Depression

First Posted Date: 2008-10-03

Last Posted Date: 2013-01-21

Lead Sponsor: Yale University

Target Recruit Count: 23

Registration Number: NCT00765752

Locations: 🇺🇸
Yale Depression Research Program, New Haven, Connecticut, United States

Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)

Phase 4

Withdrawn

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Paliperidone

First Posted Date: 2008-10-03

Last Posted Date: 2016-08-23

Lead Sponsor: Yale University

Registration Number: NCT00766064

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)

Early Phase 1

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Duloxetine

First Posted Date: 2008-09-30

Last Posted Date: 2015-04-23

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT00763178

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Domperidone in Refractory Gastroparesis

Phase 2

Terminated

Conditions: Gastroparesis

Interventions: Drug: Domperidone

First Posted Date: 2008-09-26

Last Posted Date: 2017-08-18

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT00760461

Locations: 🇺🇸
Yale Digestive Diseases 40 Temple St, Suite 1A, New Haven, Connecticut, United States

Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China

Phase 3

Completed

Conditions: Opiate Dependence
HIV Infections

Interventions: Behavioral: Drug counseling
Behavioral: Behavioral Drug and HIV Risk Reduction Counseling (BDRC)

First Posted Date: 2008-09-23

Last Posted Date: 2020-03-30

Lead Sponsor: Yale University

Target Recruit Count: 45

Registration Number: NCT00757744

Locations: 🇺🇸
Yale University School of Medicine - CMHC, New Haven, Connecticut, United States
🇨🇳
Wuhan Center for Disease Control and Prevention, Wuhan, Hubei, China

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Early Phase 1

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: ganirelix acetate
Drug: methyl testosterone

First Posted Date: 2008-09-23

Last Posted Date: 2016-07-04

Lead Sponsor: Yale University

Target Recruit Count: 28

Registration Number: NCT00757185

Locations: 🇺🇸
John B. Pierce Laboratory, New Haven, Connecticut, United States

Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).

Phase 3

Completed

Conditions: Alcohol Dependence
Stress Disorders, Post-Traumatic

Interventions: Drug: Prazosin
Drug: Placebo

First Posted Date: 2008-08-29

Last Posted Date: 2020-03-19

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT00744055

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy